Newman Stephen L 4
4 · CADENCE PHARMACEUTICALS INC · Filed Mar 15, 2013
Insider Transaction Report
Form 4
Newman Stephen L
Director
Transactions
- Award
Stock option (right to buy)
2013-03-13+37,500→ 37,500 totalExercise: $5.40Exp: 2023-03-13→ common stock (37,500 underlying)
Footnotes (2)
- [F1]Shares shall vest in thirty-six equal monthly installments on the first day of each calendar month subsequent to the date of grant, subject to such director's continuing service on our board of directors on those dates.
- [F2]Not applicable to this transaction.